No CrossRef data available.
Article contents
De klinische praktijk van de medicamenteuze behandeling van alcoholverslaving
Published online by Cambridge University Press: 18 September 2015
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Acamprosaat bij de behandeling van alcoholisme
- Information
- Copyright
- Copyright © Scandinavian College of Neuropsychopharmacology 1999
References
Literatuur
1American Psychiatric Association Practice guidelines for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. AmJ Psychiatry, 1995; 152: 28–35.Google Scholar
2American Psychiatric Association, Behande-lingsrichtlijnen alcohol, cocaine en opiaten. Lisse: S wets & Zeidinger, 1998.Google Scholar
3Pharmacotherapy for Alcohol Dependence. Summary, Evidence report/Technology Assessment. Agency for Health care Policy and Research: Rockville, MD, 1999, nr. 3.Google Scholar
4Geerlings, PJ, Brink, W van den, Schippers, GM red. Behandelingsstrategieën bij alcohol-problemen, Houten/Diegem: Bohn, Stafleu van Loghum, 1996.Google Scholar
Hoes, MJAM. Alcoholism: History, diagnosis, comorbidity and treatment. Int Psychiat Today 1999: 4–9.Google Scholar
6Fuller, RK, Branchy, L, Brightwell, DR, et al.Disulfiram treatment of alcoholism: A Veterans administration cooperative study. Journal of Nervous and Mental Diseases, 1986; 256: 1449–55.Google ScholarPubMed
7Hoes, MJAM. Relapse prevention in alcoholics. A review of acamprosate versus naltrexone. Clin Drug Invest 1999; 17: 211–6.CrossRefGoogle Scholar